Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 125 for

Edit search filters
  1. Two Cancers, One Gene. Why Some People In Families Develop Melanoma Or Pancreas Cancer, While Still Others Never Develop Cancer (TCOG)

    Rochester, MN

  2. Melanoma In-transit Tissue Bank And Molecular Analysis For Personalized Therapies

    Jacksonville, FL, Rochester, MN

  3. Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

  4. Melanoma Registry

    Jacksonville, FL

  5. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System Tumors

    Rochester, MN

  7. Detection of Mutant Circulating Tumor (CT)Dna in Uveal Melanoma With Development of a Droplet Digital Pcr (Ddpcr) Assay

    Rochester, MN

  8. Validation Of A Blood Assay For The Detection Of BRAF Mutation Status In Patients With Metastatic Melanoma

    Rochester, MN

  9. A Study To Develop A Biorepository Of Blood Samples From Cancer Patients Participating In The Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. Diagnosing Lymphangioleiomyomatosis from Glycoprotein Non-Metastatic Melanoma Protein B

    Rochester, MN

.

Mayo Clinic Footer